Clinical trials are notoriously slow, expensive, and manual—Medable is betting that agentic AI can change that. With $95.8M in revenue and a half-billion in funding, they’re not just digitizing forms; they’re attempting to automate the entire trial workflow.

"Medable isn't just selling software; they're selling the elimination of clinical trial bottlenecks."

The product strategy is clear: combine best-in-class eCOA (electronic Clinical Outcome Assessment) with an 'agentic AI' layer. While competitors digitize paper forms, Medable aims to make the data collection and analysis autonomous. Their tech stack—anchored by AWS and Cloudflare—suggests scalability, while the use of Tailwind and Ant Design points to a modern, component-driven frontend.

• The 'Agentic AI' buzzword is real here: Moving beyond static forms to dynamic, automated trial management.
• Traffic is dominated by brand searches, signaling strong outbound sales but weak inbound funnel for new leads.
• The lack of Trustpilot reviews is standard for high-ticket enterprise healthtech, where sales happen in boardrooms, not on review sites.